The V Foundation Selects 2012 Translational Grant Recipients
The V Foundation for Cancer Research, one of the nation’s leading cancer research foundations, has announced the 10 recipients of its 2012 Translational Grants. Each grant is for a $600,000 three year commitment.
The Translational grant program, created in 2000, strives to bridge the gap between the laboratory and patient bedside. The goal of this grant program is to bring the benefits of new basic-level understandings to patients more quickly and efficiently. This year’s recipients’ work includes research in concentrations including leukemia, pediatric, prostate and breast cancers.
The competitive grant application process is supervised by The V Foundation’s Scientific Advisory Board. The Board, comprised of notable physicians and research scientists from prominent universities and cancer centers, ensures that all proposals meet the highest standards of scientific merit. The Board consistently selects the best research projects dedicated to curing cancer.
“Our Scientific Advisory Board selected the 10 translational projects most likely to benefit cancer patients from more than 60 promising proposals, “,” said Robert C. Bast, Jr., M.D., Vice President for Translational Research at M.D. Anderson Cancer Center and a member of the Scientific Advisory Board. “These grants are awarded to investigators at centers across the country who are preventing, detecting and treating cancers at several different sites.”
Featured July 7th
The V Foundation’s Team V Races to Achieve Victory Over Cancer in Chicago + NYC MarathonsRead More
Featured July 6th
2021 ESPYS and Sports Humanitarian Awards to Benefit the V Foundation’s Stuart Scott FundRead More
Featured May 11th
The V Foundation and Parker Institute for Cancer Immunotherapy Announce Partnership to Co-Fund GrantsRead More